Page 21




'Criteria of speaker selection is important to convey the quality level' OMICS Group of Conferences is known for organising conferences on issues vital to the Indian and global pharma industry. Dr Srinubabu Gedela, Director, OMICS Group of Conferences, reveals more to Sachin Jagdale about pharma conferences and their plans for the Indian pharma industry Give us some background information about OMICS' 2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs. The conference will be held from November 23-24, 2012 at HICC Hyderabad, India. The two-day conference will have four sessions divided into 11 tracks and will witness a plethora of 60 speakers, 350 delegates and about 200 poster presenters from all over the world, together at a single platform to discuss the ongoing research and advancements in the field of pharma regulatory affairs. Can you describe the nature of the crowd that would participate in this event? It is going to see a gathering of regulatory experts from across the industry and academia, who will discuss the latest updates and pressing issues in the field of pharma regulatory affairs. The grandeur of the event can be made out from the number of speakers and delegates that are going to be present at the event, which is expected to

November 16-30, 2012


reach a count of almost 400, flying from over 15 countries. What will the delegates gain from the conference? Initiation of cross-border co-operations between scientists and institutions is facilitated at the conference. This is an excellent opportunity for delegates from universities and institutions to interact with leading industry experts and debate on the latest regulatory updates. Experts from Food and Drug Administration (FDA) are anticipated as chief

guest for the meeting while prominent personalities like Dr Prakash Nagarkatti (University of South Carolina, US), Dr Patrick L Leoni (Euromed Management, France), Dr Jagat RJ Kanwar (Deakin University), Dr SV Krishna Prasad (Cito Healthcare, India) and Dr Shivanand P Puthli (Panacea Biotech, India) will be the keynote speakers. Pharma2012 is supported by many organisations like RxPharma, P h a r m a P h o r u m ,, Thompson

Reuter, Innovaro, Conferensum and Aark Store. Auriga Research is going to be the event partner. Besides regulatory affairs, which other pharma-related topics have been covered/ discussed in OMICS' conferences till now? Bioavailability and Bioequivalence ● International Conference and Exhibition on Bioequivalence & Bioavailability: Pharmaceutical R&D Summit, March 1-3, 2010; Marriott Convention Centre, Hyderabad, India with a theme 'Practical Solutions to Pharmaceutical Bioequivalence/Bioavaila bility Implementation.' ● 2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R&D Summit, June 6-8, 2011; Las Vegas, US with a theme 'Analyze Novel Approaches of Bioequivalence & Bioavailability Studies.' ● 3rd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R&D Summit, March 26-28, 2012; Marriott Convention Centre, Hyderabad, India

Pharmexcil expects Ministry notification on branding for drug exports within a week PG28

Symposium on evolution of gas chromatography in India - Past, Present and Future PG33

Event briefs PG34

Pharma M&A focuses on increasing product pipelines in Oct 2012 PG38 Aerosol Promotion Council organises 'APC Conference and Exhibition-2012 PG40



Express Pharma November 16-30, 2012 Part - 1  

Express Pharma November 16-30, 2012 Part - 1